Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer
Conditions:   Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer;   Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer;   Metastatic Gastric Adenocarcinoma or Cancer;   Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Interventions:   Drug: zolbetuximab;   Drug: placebo;   Drug: oxaliplatin;   Drug: leucovorin;   Drug: fluorouracil
Sponsor:   Astellas Pharma Global Development, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 1, 2019 / by / in
Comments